Emergence of COVID-19 Variant XFG not linked to Higher Rates of Sore Throat or altered severity: Evidence from participatory surveillance in The Netherlands
Carstens, G.; Kozanli, E.; Han, W.; Gruters, M.; van Gageldonk-Lafeber, R.; van den Hof, S.; van Hoek, A. J.; Eggink, D.
Show abstract
Since the emergence of SARS-CoV-2, the virus causing COVID-19, it evolved into different lineages and sub-variants. New genetic variants of the virus can result in a different transmissibility, immune evasion, as well as different symptoms and severity of disease. When new variants appear, media report often anecdotal observations of unique or differentiating symptomatology of these new variants. Here, we investigate reported elevated levels of sore throat linked to the new variant XFG using an evidence-based method.
Matching journals
The top 12 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A cohort study of Post COVID-19 Condition across the Beta, Delta and Omicron waves in South Africa: 6-month follow up of hospitalised and non-hospitalised participants 94%
- Day by day symptoms following positive and negative PCR tests for SARS-CoV-2 in non-hospitalised health-care workers: a 90-day follow-up study 92%
- No difference in risk of hospitalisation between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in Norway 92%
Similar papers in this journal
- Using routine emergency department data for syndromic surveillance of acute respiratory illness in Germany, week 10-2017 and 10-2021 94%
- Shorter serial intervals in SARS-CoV-2 cases with Omicron variant compared to Delta variant in the Netherlands, 13 – 19 December 2021 94%
- Higher risk of SARS-CoV-2 Omicron BA.4/5 infection than of BA.2 infection after previous BA.1 infection, the Netherlands, 2 May to 24 July 2022 93%
Similar papers in this journal
- A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads 92%
- Anti-SARS-CoV-2 Antibodies Persist for up to 13 Months and Reduce Risk of Reinfection 91%
- The COVID-19 Pandemic as an Opportunity for Unravelling the Causative Association between Respiratory Viruses and Pneumococcus-Associated Disease in Young Children: A Prospective Study 91%
Similar papers in this journal
- Characterization of SARS-CoV-2 ORF6 deletion variants detected in a nosocomial cluster during routine genomic surveillance, Lyon, France 93%
- Live virus neutralisation testing in convalescent patients and subjects vaccinated against 19A, 20B, 20I/501Y.V1 and 20H/501Y.V2 isolates of SARS-CoV-2 90%
- Naturally occurring SARS-CoV-2 gene deletions close to the spike S1/S2 cleavage site in the viral quasispecies of COVID19 patients 90%
Similar papers in this journal
- Household transmission of SARS-CoV-2; a prospective longitudinal study showing higher viral load and transmissibility of the Alpha variant compared to previous strains 94%
- Dynamics of a dual SARS-CoV-2 strain co-infection on a prolonged viral shedding COVID-19 case: insights into clinical severity and disease duration 93%
- SARS-CoV-2 N501Y introductions and transmissions in Switzerland from beginning of October 2020 to February 2021 – implementation of Swiss-wide diagnostic screening and whole genome sequencing 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.